chap 39 pharm asthma
the two main physiocogic processes of the respiratory system are ---- and ----
diffusion and ventilation
a machine that vaporizes a liquid drug into a fine mist that can be inhaled is called a -----
the two primary disorders classified as copd are .....
emphysema and chronic bronchitis
the process of gas exchange is called.....
the respiratory rate which is normally ---per minute can be modified by factors such as ----,-----,----,and -----
stimulation of the parasympathetic nervous system results in bronchiole----
----uses a propellant to deliver a measured dose of drug to the lung during each breath
-----is a severe prolonged form of asthma that is unresponsive to drug therapy and may lead to respiratory failure.
goals of drug therapy for asthma are twofold to ---- acute bronchospasm and to rduce the --- of asthma attacks
albuterol is an....
selective beta 2 agonist
bedesonide (pulmicort turbuhaler)
salmeterol (servent) is a ....
aminophylline (truphylline) is a .....
when assessing a pt. for a respiratory disorder what three things are you looking at
what classes would you see used for asthma
the nurse should educate the patient that serevent is not indicated for the termination of acute attacks for what reason
it takes to long to act
when administering glucocorticoids for the prophylaxis of nonpersistent asthma the nurse should know that these drugs are given most commonly by what route
glucocorticoids improve asthma symptoms by which of the following mechanisms
long term treatment of oral corticosteroids may cause whivh serious adverse effect
candidasis of the throat is a common complication during therapy with which class of medications
the nurse should teach patients that the primary use of mast cell inhibitors in the treatment of asthma is what
to prevent asthma attacks
patients taking accoulate or singulair shoud be taught that they will see improvement with in what time frame
why are selective beta 1 agonists ineffective for treating asthma
there are not beta 1 receptors in smooth muscle
chap 39 pharm asthma